FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Rimegepant only product in oromucosal dose form Count of base of active ingredient False un Inferred relationship Some
    Satralizumab only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only satralizumab in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyanocobalamin 500 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only azacitidine in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only azacitidine in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Somapacitan only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only somapacitan in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only clascoterone (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only clascoterone in cutaneous dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Clascoterone 10 mg/g cutaneous cream Count of base of active ingredient False un Inferred relationship Some
    Clascoterone 10 mg/g cutaneous cream Has concentration strength denominator value False un Inferred relationship Some 1
    Pralsetinib only product Count of base of active ingredient False un Inferred relationship Some
    Pralsetinib only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Fluoroestradiol (18-F) only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only fluoroestradiol (18-F) in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Fluoroestradiol (18-F) 100 mCi/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Fluoroestradiol (18-F) 100 mCi/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only triheptanoin (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Triheptanoin only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Triheptanoin 960 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Triheptanoin 960 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only remimazolam (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Remimazolam only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Abametapir only product Count of base of active ingredient False un Inferred relationship Some
    Abametapir only product in cutaneous dose form Count of base of active ingredient False un Inferred relationship Some
    Abametapir 7.4 mg/g cutaneous emulsion Count of base of active ingredient False un Inferred relationship Some
    Abametapir 7.4 mg/g cutaneous emulsion Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only copper (64-Cu) dotatate (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Copper (64-Cu) dotatate only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Arsenic trioxide 1 mg/mL solution for infusion Count of base of active ingredient False un Inferred relationship Some
    Arsenic trioxide 1 mg/mL solution for infusion Has concentration strength denominator value False un Inferred relationship Some 1
    Arsenic trioxide 1 mg/mL solution for infusion Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Arsenic trioxide only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Ipilimumab 5 mg/mL solution for infusion Count of base of active ingredient False un Inferred relationship Some
    Ipilimumab 5 mg/mL solution for infusion Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Idelalisib only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Ceritinib 150 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Ceritinib 150 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product) Count of active ingredient False un Inferred relationship Some
    Vaccine product containing only Influenza A virus subtype H5N1 antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Chondroitin only product Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely semaglutide 3 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Semaglutide 7 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Semaglutide 7 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely semaglutide 14 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only coagulation factor VII (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Coagulation factor V only product Count of base of active ingredient False un Inferred relationship Some
    Hydroxyapatite only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only porcine isophane insulin in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only human isophane insulin in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Hepatitis A virus HM-175 strain antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Live attenuated Human alphaherpesvirus 3 Oka-Merck strain only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Influenza virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Hepatitis A virus GBM strain antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dulaglutide 1.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dulaglutide 1.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Dulaglutide 3 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Dulaglutide 3 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Dulaglutide 6 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Dulaglutide 6 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Dulaglutide 9 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Dulaglutide 9 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Dulaglutide only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Crisaborole 20 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
    Crisaborole 20 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ixekizumab 80 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely minocycline (as minocycline hydrochloride) 15 milligram/1 gram conventional release cutaneous foam (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Dupilumab 150 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Dupilumab 150 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1

    Start Previous Page 214 of 215 End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start